发明名称 |
High-purity phospholipids |
摘要 |
Novel synthetic routes, which are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids, are disclosed. Particularly, novel methods for efficiently preparing compounds having a glycerolic backbone and one or more oxidized moieties attached to the glycerolic backbone, which are devoid of column chromatography are disclosed. Further disclosed are novel methods of introducing phosphorus-containing moieties such as phosphate moieties to compounds having glycerolic backbone and intermediates formed thereby. Further disclosed is substantially pure 1-hexadecyl-2-(4′-carboxy)butyl-sn-glycero-3-phosphocholine (CI-201). |
申请公布号 |
US9566288(B2) |
申请公布日期 |
2017.02.14 |
申请号 |
US201514630770 |
申请日期 |
2015.02.25 |
申请人 |
Vascular Biogenics Ltd. |
发明人 |
Halperin Gideon;Kovalevski-Ishai Eti |
分类号 |
A61K31/685;A61K31/661;C07F9/141;C07F9/10 |
主分类号 |
A61K31/685 |
代理机构 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
代理人 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
主权项 |
1. A method of treatment of a disease or disorder comprising administering to a subject in need of treatment a therapeutically effective amount of substantially pure 1-hexadecyl-2-(4′-carboxy)butyl-sn-glycero-3-phosphocholine, wherein the disease or disorder is selected from the group consisting of atherosclerosis, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, stenosis, restenosis, and in-stent-stenosis. |
地址 |
Or Yehuda IL |